TI - Real-World Outcomes of Neoadjuvant Pembrolizumab plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: A Multicenter Study from Türkiye
PT - Journal Article
DP - 2026
TA - EJMI
PG - 171-178
VI - 10
IP - 2
AID - 266171 [doi]
4100 - https://dx.doi.org/10.14744/ejmi.266171
SO - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION,2026 10(2): 171